Syros
formerly Syros PharmaceuticalsIPOPublic · Cambridge, United States · Founded 2012 · $38.0M raised
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2012
- Business Model
- B2B
- Website
- syros.com
- Total Funding
- $38.0M
- Last Round
- Venture RoundDec 2020
- Rounds
- 6
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 9 funding rounds and 10 investors for this company. The full record is or through the API.
About
Syros Pharmaceuticals (NASDAQ: SYRS) is a biopharmaceutical company co-founded by Flagship Pioneering that is advancing a new wave of medicines to control the expression of genes. The company's platform represents the first dedicated effort to systematically identify disease-causing alterations in gene expression and develop therapies that modulate gene activity for diseases resistant to traditional genomics approaches. Syros is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies and other cancers.
Summary
Syros is a Biotech company based in Cambridge, United States, founded in 2012. It has raised $38.0M in total across 6 rounds, most recently a Venture Round in Dec 2020. Investors include Flagship Pioneering, Polaris Partners and ARCH Venture Partners.
Funding & Exit History
Jun 2023
Sign up to see all 9 events
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/syros"><img src="https://indexed.vc/api/badge/company/syros" alt="Syros on Indexed.vc" width="260" height="76" /></a>